Korea may speed development of new drugs

Published: 2010-11-09 06:56:00

Updated: 2010-11-09 06:56:00

Local drugmakers should focus on lead compounds that have been discontinued in early clinical stage, to elevate the success rate of new drugs’ development, said a local professor.

In a scientific seminar, Professor Kim Hyung-choon of Kangwon University said that Korea’s pharmaceutical firms sh...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK